Apimeds Pharmaceuticals US, Inc (APUS) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Hopewell, NJ, 美国. 现任CEO为 Youngjik Cho.
APUS 拥有 IPO日期为 2025-05-09, 2 名全职员工, 在 American Stock Excha, 市值为 $2.36M.
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
